Fidelity Momentum Factor ETF (ARCA: FDMO)

Latest News for Fidelity Momentum Factor ETF (ARCA:FDMO)

Fidelity Momentum Factor ETF

Long Ideas

Broad U.S. Equity ETFs

Movers

Trading Ideas

ETFs

AAPL

FDMO

MSFT

QMOM

SPMO

3 Momentum ETFs Hitting All-Time Highs

Markets

A Momentum ETF With Some Steadiness

WIIM

RGEN

Repligen shares are trading higher as life sciences stocks gain following strong earnings from Danaher.

Cantor Fitzgerald analyst Louise Chen reiterates Cidara Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDTX#NASDAQ">CDTX</a>) with a Overweight.

News

Reiteration

Analyst Ratings

CDTX

Cantor Fitzgerald Reiterates Overweight on Cidara Therapeutics

Keefe, Bruyette &amp; Woods analyst Wood Lay maintains Sierra (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSRR#NASDAQ">BSRR</a>) with a Market Perform and lowers the price target from $24 to $23.

Price Target

BSRR

Keefe, Bruyette & Woods Maintains Market Perform on Sierra, Lowers Price Target to $23

Lufax Holding shares are trading lower following a Q1 revenue miss. The company also announced a CFO transition.

Metlife's Metlife Investment Management (MIM) Announced That It Has Brought Together Its Public Fixed Income And Private Capital Offerings Into A Unified Structure Led By Jude Driscoll, Who Was Named MIM's Global Head Of Fixed Income And Private Capital

NextEra Energy Partners shares are trading higher following Q1 earnings.

Offerings

MAIA

MAIA Biotechnology Announces $1M Private Placement Of 494,096 Shares At $2.034/Share

OPCH

Option Care Health shares are trading higher after the company reported a Q1 earnings beat and raised the bottom end of its 2024 guidance range.

LOCL

Local Bounti Disclosed The Opening Of Its New Controlled Environment Agriculture Facility In Pasco, Washington On May 7

Keefe, Bruyette &amp; Woods analyst Kelly Motta maintains Bank of Hawaii (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOH#NYSE">BOH</a>) with a Underperform and raises the price target from $55 to $58.

Keefe, Bruyette & Woods Maintains Underperform on Bank of Hawaii, Raises Price Target to $58

SNAL

Snail Launched Bellwright In Early Access Move To Bolster Its Standing In The Market And Reaffirm Its Commitment To Pioneering New Gaming Experiences

Kimberly-Clark Corporation&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) shares are gaining in the&nbsp;<a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener">premarket session on Tuesday</a>.
The company reported first-quarter adjusted earnings per share of $2.01,&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/04/n38375057/kimberly-clark-announces-first-quarter-2024-results-and-raises-2024-outlook" rel="noreferrer noopener">beating the analyst consensus of $1.63</a>.
Quarterly revenues of $5.149 billion topped the street view of $5.085 billion. Net sales were down 1%, with organic sales growth of 6% <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">versus the prior year.</a>
Gross margin was 37.1%, up 390 basis points versus the prior year, driven by organic net sales growth and gross productivity gains.
Price-led gains reflected necessary pricing actions to address higher local costs in hyperinflationary economies, mainly in&nbsp;Argentina.&nbsp;
Volume and mix were positive across&nbsp;North America, developing and emerging (D&amp;E), and developed markets (represented&nbsp;Australia,&nbsp;South Korea, and Western/Central Europe).
Adjusted operating profit increased by 14% despite an unfavorable impact of 12 percentage points from currency translation, primarily driven by hyperinflationary economies.
Year-to-date capital spending was&nbsp;$194 million&nbsp;compared to $201&nbsp;million last year.&nbsp;
The company returned&nbsp;$452 million&nbsp;to shareholders through dividends and repurchases of common stock.&nbsp;
Total debt was&nbsp;$8 billion&nbsp;as of&nbsp;March 31, 2024, consistent with&nbsp;December 31, 2023.
Outlook:&nbsp;Organic net sales&nbsp;is&nbsp;now&nbsp;expected&nbsp;to grow mid-single digits (<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">prior view: low-to mid-single-digit growth</a>).&nbsp;
The company now expects&nbsp;reported net sales&nbsp;to&nbsp;be negatively impacted&nbsp;by 400 basis points of currency translation and 120 basis points from divestitures (prior view: 300 basis points and 60 basis points, respectively).
Adjusted EPS&nbsp;is now expected&nbsp;to grow at a low-teens percentage rate on a constant-currency basis (prior view: high-single-digit growth).
Price Action: KMB shares are trading higher by 5.5% to $136.02 premarket at the last check Tuesday.
Photo via Wikimedia Commons

Earnings

Equities

Guidance

General

Kimberly-Clark +5% After Q1 Results - Here's Why

Wells Fargo analyst Andrew Nowinski upgrades Datadog (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>) from Equal-Weight to Overweight and raises the price target from $130 to $150.

Upgrades

DDOG

Wells Fargo Upgrades Datadog to Overweight, Raises Price Target to $150

Hewlett Packard Enterprise Launched Wi-fi 7 Access Points (APs) That Provide Up To 30% More Capacity For Wireless Traffic Than Competitive Products

Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) is gearing up to report its <a href="https://www.benzinga.com/quote/AAPL/earnings">fiscal second-quarter (Q2) earnings</a>.
Wall Street expects the Cupertino, California-based company to report $1.51 in EPS and $90.83 billion in revenue on May 2 after the market closes. Until then, Apple analysts are drawing attention to the stock&#8217;s promising outlook and four key catalysts. 
Apple Analyst: BofA Securities analyst Wamsi Mohan reiterated a Buy rating for Apple stock with a price objective of $225, reflecting a potential upside of 36.4%.
Also Read: &#8216;<a href="https://www.benzinga.com/news/24/04/38354891/apple-shot-itself-in-the-foot-telegram-founder-says-cupertino-iphone-market-share-in-china-will-keep">Apple Shot Itself In The Foot:&#8217; Telegram Founder Says Cupertino iPhone Market Share In China Will &#8216;Keep Shrinking&#8217;</a>
The Apple Thesis: Mohan&#8217;s recommendation to buy Apple stock is grounded on four catalysts, making it a &#8220;top pick for 2024&#8221;:
<ol>
<li>Re-upping the capital return at earnings in May </li>
<li>Gen AI, or generative artificial intelligence, announcements at the Worldwide Developers&#8217; Conference (WWDC) in June, </li>
<li>The launch of iPhone 16 in the fall, and </li>
<li>Re-acceleration in gross profit dollar growth each quarter.</li>
</ol>
<h3 class="wp-block-heading">Strong iPhone Upgrade Cycle In FY 2025</h3>
Mohan anticipates a strong iPhone upgrade cycle in FY 2025, driven by the demand for cutting-edge hardware to support Gen AI features. 
Additionally, there are optimistic expectations for sustained growth in Apple&#8217;s Services revenue segment. 
Mohan also predicts higher margins stemming from the use of internally developed silicon. Moreover, Apple&#8217;s commitment to continuing its capital return program is seen as a positive factor that could bolster investor sentiment.
<h3 class="wp-block-heading">AI Features To Increase Institutional Ownership Of Apple Stock</h3>
The analyst further suggests that the incorporation of AI features could attract increased institutional ownership of Apple stock. 
Expect any legal issues that come up to be manageable, Mohan says.
<h3 class="wp-block-heading">Key Expectations From Q2 Earnings &#8211; New Buyback Authorization In The Cards?</h3>
With regard to the Q2 report, Mohan foresees a strong performance overall, but he warns that a lower guidance for F2Q might lead to a pullback in shares. 
Despite this caution, Mohan expects Services revenue growth and margins to remain robust, with the anticipation of some Vision Pro sales in the upcoming quarters. 
Additionally, investors can look forward to a new buyback authorization during the F2Q earnings call, indicating Apple&#8217;s commitment to returning capital to shareholders.
AAPL Price Action: Apple stock was trading at $167.13 at the time of publication.
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38362506/apples-next-big-leap-how-ai-software-and-wwdc-announcements-could-fuel-growth">Apple&#8217;s Next Big Leap: How AI Software and WWDC Announcements Could Fuel Growth</a>
Image: Shutterstock

Analyst Color

Previews

Tech

Apple Is A 'Top Stock Pick For 2024,' Analyst Says: 4 Catalysts To Look For In Next Earnings Report

GM CFO Says Co Expects To Return To Profits In Q2 In China

Agilent shares are trading higher in possible sympathy with Danaher, which reported better-than-expected Q1 financial results.

Cantor Fitzgerald analyst Kristen Kluska reiterates Abeona Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABEO#NASDAQ">ABEO</a>) with a Overweight and maintains $36 price target.

ABEO

Cantor Fitzgerald Reiterates Overweight on Abeona Therapeutics, Maintains $36 Price Target

Charles River shares are trading higher in possible sympathy with Danaher, which reported better-than-expected Q1 financial results.

CRVL

CorVel Disclosed New Integrations For Managed Care Services Enabling Partners To Increase Connectivity And Create A Seamless Workflow Experience

Fidelity Momentum Factor ETF declares quarterly distribution of $0.0890

Growth Stocks Are Less Expensive Than Traditional Measures Imply

Latest Memo From Howard Marks: Further Thoughts On Sea Change

Value's U-Turn

Fidelity Momentum Factor ETF declares $0.097 dividend

Capital Markets Outlook: Q1 2024

You'd Be Surprised Which Four Vanguard ETFs Have Consistently Beaten Their Category Averages

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Fidelity Momentum Factor ETF (ARCA:FDMO)

Wednesday, February 05, 2020

Thursday, October 26, 2017